Treatment with denosumab reduces secondary fracture risk in women with postmenopausal osteoporosis.
Climacteric
; 18(6): 805-12, 2015.
Article
in En
| MEDLINE
| ID: mdl-26029985
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Spinal Fractures
/
Bone Density Conservation Agents
/
Denosumab
/
Hip Fractures
/
Lumbar Vertebrae
Type of study:
Clinical_trials
/
Etiology_studies
/
Incidence_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Climacteric
Journal subject:
GINECOLOGIA
Year:
2015
Document type:
Article
Affiliation country:
España